Exclusive

Waters launches AI-powered Peak Integration to strengthen software capabilities

Singapore, Oct. 30 -- Waters Corporation has announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine learning, and automation cloud-based capabilities dir... Read More


DKSH to establish healthcare platform in Middle East and scale up capabilities with acquisition of NewBridge Pharma

Singapore, Oct. 30 -- DKSH has signed an agreement to acquire 100% of NewBridge Pharmaceuticals, a Dubai-headquartered healthcare commercialisation platform with operations across 14 markets in the ME... Read More


PDRadiopharma injects JPY 16.5 B into new manufacturing facility in Japan

Singapore, Oct. 29 -- PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development of peptide- based therapeutics and PDRadiopharma Inc., a wh... Read More


Australia's Audax Biosciences inks immuno-oncology deal worth $1.34 B deal with Astellas Pharma

Singapore, Oct. 29 -- Japan-based Astellas Pharma Inc. has entered into an exclusive option and license agreement for DAX-044, Audax's lead immuno-oncology AVIKINE(R) candidate. Under the agreement, ... Read More


Jiahui launches International Cell Therapy Centre to expand global access to CAR-T treatment

Singapore, Oct. 29 -- Jiahui International Hospital has launched Jiahui International Cell Therapy Centre (JICC), building on landmark CAR-T cases and multidisciplinary expertise to serve patients fro... Read More


Singapore approves Merck's CAPVAXIVE 21-valent pneumococcal conjugate vaccine

Singapore, Oct. 29 -- American multinational pharmaceutical company Merck (Known as Merck Sharp & Dohme or MSD outside the United States and Canada) has announced that the Health Sciences Authority (H... Read More


M42, American University in Dubai partner to advance healthcare talent

Singapore, Oct. 29 -- M42 and the American University in Dubai (AUD) have signed a Memorandum of Understanding (MoU) to expand practical learning opportunities for biology and pre-medical students, st... Read More


"The Future of Brain-Computer Interfaces Will Be Measured by Independence, Not Laboratory Performance"

Singapore, Oct. 29 -- Brain-computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental demonstrations towards practical applications that could transf... Read More


Gilead buys oral IL-23R inhibitor programme from China's PepStar for $1.27 B

Singapore, Oct. 28 -- US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, including lead asset HCXT-2001, from Hong Kong-based PepStar... Read More


CELSET launches Korean Botulinum Toxin Type A brand for International Markets

Singapore, Oct. 28 -- CELSET INC., a Korean biotechnology company specialising in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand ... Read More